UCB Hero Image


UCB is a global biopharmaceutical company focused on creating value for people living with severe diseases.

1950 Lake Park Drive

Smyrna, GA 30080


+1 (770) 970-7500



Researcher Profile: Eddy Han-Burgess image

Researcher Profile: Eddy Han-Burgess

Eddy Han-Burgess and his team are using a mix of mathematical modeling, big data and artificial intelligence in hopes of more quickly identifying the unique characteristics of someone’s condition.

Researcher Profile: Henrik Klitgaard image

Researcher Profile: Henrik Klitgaard

With nearly 30 years of experience in biopharmaceutical research, Dr. Henrik Klitgaard has dedicated his life to pursuing new and better treatments for patients with epilepsy.

Taking Control of Epilepsy image

Taking Control of Epilepsy

As the most common serious neurological condition in the U.S., epilepsy affects roughly 3.4 million Americans. It's what drives biopharmaceutical researchers to fight back with innovative medicines like targeted treatments that could transform the lives of patients living with the disease.

Pursuing Novel and Targeted Treatments for Epilepsy image

Pursuing Novel and Targeted Treatments for Epilepsy

Epilepsy is a complex condition, and it will take an equally complex approach to put an end to the disease. America's biopharmaceutical companies will not be satisfied until that goal is reached.

Researcher Profile: Luiz Miguel Camargo, PhD image

Researcher Profile: Luiz Miguel Camargo

As director of innovation networks at UCB, Dr. Luiz Miguel Camargo helps identify tools that researchers use to discover transformative medicines.

Researcher Profile: Victor Sloan Image

Researcher Profile: Victor Sloan

As vice president and development strategy lead at UCB, Victor Sloan has worked in the field of rheumatology since the early 1990's.

Tackling Epilepsy to Deliver Value to Patients

Tackling Epilepsy to Deliver Value to Patients

Brain diseases affect one in six people around the world. The range of conditions affecting the central nervous system – and how they impact the patient – is wide, making unlocking the science behind them complicated.